Article Information
History
- November 24, 2022.
Article Versions
- You are currently viewing Version 1 of this article (November 24, 2022 - 08:19).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Gila Lustig1,*,
- Yashica Ganga2,*,
- Hylton Rodel1,3,
- Houriiyah Tegally4,
- Laurelle Jackson2,
- Sandile Cele2,5,
- Khadija Khan2,5,
- Zesuliwe Jule2,
- Kajal Reedoy2,
- Farina Karim2,5,
- Mallory Bernstein2,
- Mahomed-Yunus S. Moosa6,
- Derseree Archary1,
- Tulio de Oliveira4,7,8,
- Richard Lessells4,
- Salim S. Abdool Karim1,9 and
- Alex Sigal1,2,5,*
- 1Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
- 2Africa Health Research Institute, Durban, South Africa
- 3Division of Infection and Immunity, University College London, London, UK
- 4KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa
- 5School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
- 6Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa
- 7Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa
- 8Department of Global Health, University of Washington, Seattle, USA
- 9Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States
- ↵#Corresponding author; email: alexander.sigal{at}gmail.com
↵* Equal contribution
Posted November 24, 2022.
SARS-CoV-2 evolves increased infection elicited cell death and fusion in an immunosuppressed individual
